Augmentation of adoptively transferred experimental allergic encephalomyelitis by administration of a monoclonal antibody specific for LFA-1α
Authors:
- 31 March 1993
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 43 (1-2) , 161-167
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrinNature, 1992
- Signaling by lymphocyte function-associated antigen 1 (LFA-1) in B cells: enhanced antigen presentation after stimulation through LFA-1.Journal of Experimental Medicine, 1992
- Chimeric cytotoxin IL2-PE40 inhibits relapsing experimental allergic encephalomyelitisJournal of Neuroimmunology, 1991
- EVIDENCE THAT ANTI-LFA-1 IN VIVO IMPROVES ENGRAFTMENT AND SURVIVAL AFTER ALLOGENEIC BONE MARROW TRANSPLANTATIONTransplantation, 1990
- Clonal Modulation of Experimental Allergic Encephalomyelitis by a Monoclonal Antibody Directed to the T-Cell ReceptorAnnals of the New York Academy of Sciences, 1988
- In vivo administration of anti-CD4 monoclonal antibody prolongs survival in longtailed macaques with experimental allergic encephalomyelitisClinical Immunology and Immunopathology, 1987
- LFA-1 and other accessory molecules functioning in adhesions of T and B lymphocytesHuman Immunology, 1987
- PREVENTION OF GRAFT FAILURE BY AN ANTI-HLFA-1 MONOCLONAL ANTIBODY IN HLA-MISMATCHED BONE-MARROW TRANSPLANTATIONThe Lancet, 1986
- Reversal of Experimental Allergic Encephalomyelitis with Monoclonal Antibody to a T-Cell Subset MarkerScience, 1985
- POTENT ABILITY OF ANTI-LFA-1 MONOCLONAL ANTIBODY TO PROLONG ALLOGRAFT SURVIVAL1Transplantation, 1984